Short interest in Akari Therapeutics PLC (NASDAQ:AKTX) increased during the last reporting period, rising from 64.69K to 121.54K. This put 16.34% of the company's publicly available shares short.

Based on the recent average volume of 4.96M shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.